Cite
Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population.
MLA
Dobie, Sharon A., et al. “Survival Benefits and Trends in Use of Adjuvant Therapy among Elderly Stage II and III Rectal Cancer Patients in the General Population.” Cancer (0008543X), vol. 112, no. 4, Feb. 2008, pp. 789–99. EBSCOhost, https://doi.org/10.1002/cncr.23244.
APA
Dobie, S. A., Warren, J. L., Matthews, B., Schwartz, D., Baldwin, L.-M., & Billingsley, K. (2008). Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer (0008543X), 112(4), 789–799. https://doi.org/10.1002/cncr.23244
Chicago
Dobie, Sharon A., Joan L. Warren, Barbara Matthews, David Schwartz, Laura-Mae Baldwin, and Kevin Billingsley. 2008. “Survival Benefits and Trends in Use of Adjuvant Therapy among Elderly Stage II and III Rectal Cancer Patients in the General Population.” Cancer (0008543X) 112 (4): 789–99. doi:10.1002/cncr.23244.